COVID-19

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic

Evo sEEG electrodes used for brain mapping in epilepsy surgery EDEN PRAIRIE, Minn., May 10, 2023 (GLOBE NEWSWIRE) -- NeuroOne…

2 years ago

Bioventus Announces Divestiture of its Wound Business

DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations…

2 years ago

Medhealth Outlook Selects TOMI Environmental Solutions as One of the Top 10 Infection Control Solution Providers of 2023

FREDERICK, Md., May 10, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in…

2 years ago

Dyadic to Participate at Two Industry Events in May

JUPITER, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology…

2 years ago

Alpha Pro Tech, Ltd. Announces First Quarter 2023 Financial Results

Disposable Protective Garment Sales Increased by 10.6% to $4.4 Million Compared to the Prior Year PeriodNet sales for the first…

2 years ago

Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30…

2 years ago

AIM ImmunoTech to Discuss First Quarter 2023 Financial Results on May 16, 2023 and Host Conference Call and Webcast

OCALA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company…

2 years ago

SeqLL Provides First Quarter 2023 Financial Results

BILLERICA, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company…

2 years ago

SAB Biotherapeutics Announces Progress on U.S. FDA’s Phased Review of Company’s Groundbreaking DiversitAb™ Platform

-  FDA has approved five of seven sections in a rolling submission required for a New Animal Drug Application (NADA)…

2 years ago

Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update

Vaxxinity corporate headquarters in Cape Canaveral, Fla. Vaxxinity corporate headquarters in Cape Canaveral, Fla. (Photo: Vaxxinity)CAPE CANAVERAL, Fla., May 09,…

2 years ago